Health Condition 1: I251- Atherosclerotic heart disease of native coronary artery
Conditions
Interventions
Intervention1: Moringa capsules 2 tablets (400 mg each) with rosuvastatin 20 mg: Moringa capsules 2 tablets (400 mg each) orally after dinner with water (Earth organics) and rosuvastatin 20 mg OD.
Con
Sponsors
prathima institute of medical sciences
Eligibility
Inclusion criteria
Inclusion criteria: angiographically proven coronary artery disease fasting total triglycerides between 150 and 499 mg/dl
Exclusion criteria
Exclusion criteria: serious or dysfunctional angina pectoris (higher than Canadian Cardiovascular Society grade II) clinically manifest heart failure (higher than New York Heart Association grade II) severe cardiac arrhythmia acute liver disease or hepatic dysfunction compromised renal function (plasma creatinine >150 mol/l) history of partial ileal bypass surgery any surgical operation or any systemic inflammatory disease within 3 months before randomization malignancy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in serum triglyceride levels and High density lipoprotein (HDL) levels over a six-month spanTimepoint: 0,1,3,6 months | — |
Secondary
| Measure | Time frame |
|---|---|
| side effects of trial drug during study periodTimepoint: 0,1,2,3,4,5,6,months | — |
Countries
India
Contacts
Public ContactDr Manjiri Ranade
prathima Institute of Medical Sciences
Outcome results
None listed